Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Sep-24 4:13 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 30-Aug-24 | Private Sale (Planned) | 3,784 | $499.00 | $1,888,220.00 | (27%) 14.22K to 10.43K | |
| 21-Feb-24 4:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 4,118 | $420.58 | $1,731,950.00 | (22%) 18.34K to 14.22K | |
| 16-Feb-24 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Feb-24 | Sale (Planned) | 4,655 | $419.16 | $1,951,190.00 | (20%) 22.99K to 18.34K | |
| 16-Feb-24 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-24 | Private Sale (Planned) | 4,356 | $419.04 | $1,825,340.00 | (16%) 27.35K to 22.99K | |
| 14-Feb-24 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-24 | Sale (Planned) | 737 | $419.13 | $308,899.00 | (3%) 28.08K to 27.35K | |
| 14-Feb-24 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Private Sale (Planned) | 2,656 | $419.51 | $1,114,210.00 | (9%) 30.74K to 28.08K | |
| 12-Feb-24 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 8,048 | $422.74 | $3,402,210.00 | (21%) 38.79K to 30.74K | |
| 12-Feb-24 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Feb-24 | Payment of Exercise | 2,698 | $421.73 | $1,137,830.00 | (7%) 41.49K to 38.79K | |
| 08-Feb-24 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 7,707 | -- | -- | 23% 33.78K to 41.49K | |
| 08-Feb-24 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 30,916 | -- | -- | 1080% 2.86K to 33.78K | |
| 10-Jan-24 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Jan-24 | Private Sale (Planned) | 6,648 | $419.07 | $2,785,980.00 | (70%) 9.51K to 2.86K | |
| 15-Dec-23 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Dec-23 | Private Sale (Planned) | 13,354 | $399.42 | $5,333,800.00 | (58%) 22.86K to 9.51K | |
| 18-Oct-23 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Oct-23 | Private Sale (Planned) | 12,962 | $374.00 | $4,847,790.00 | (36%) 35.83K to 22.86K | |
| 09-May-23 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-May-23 | Sale (Planned) | 1,125 | $349.00 | $392,625.00 | (3%) 36.95K to 35.83K | |
| 09-May-23 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-23 | Private Sale (Planned) | 879 | $349.56 | $307,262.00 | (2%) 37.83K to 36.95K | |
| 04-May-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-May-23 | Sale (Planned) | 4,508 | $350.11 | $1,578,300.00 | (11%) 42.34K to 37.83K | |
| 04-May-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-23 | Private Sale (Planned) | 6,450 | $349.89 | $2,256,760.00 | (13%) 48.79K to 42.34K | |
| 28-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 13,730 | $289.12 | $3,969,620.00 | (22%) 62.52K to 48.79K | |
| 14-Feb-23 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 13,344 | $298.26 | $3,979,980.00 | (18%) 75.86K to 62.52K | |
| 03-Feb-23 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-23 | Payment of Exercise | 3,578 | $317.83 | $1,137,200.00 | (5%) 79.44K to 75.86K | |
| 03-Feb-23 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 76,578 | -- | -- | 2675% 2.86K to 79.44K | |
| 27-Jul-22 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Jul-22 | Option Exercise | 60,342 | $91.05 | $5,494,140.00 | 81% 74.6K to 134.94K | |
| 27-Jul-22 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Jul-22 | Planned Option Sale | 60,342 | $281.38 | $16,979,100.00 | (45%) 134.94K to 74.6K | |
| 27-Jul-22 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Jul-22 | Sale (Planned) | 71,737 | $281.38 | $20,185,400.00 | (96%) 74.6K to 2.86K | |
| 14-Apr-22 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Apr-22 | Private Sale (Planned) | 15,789 | $289.04 | $4,563,650.00 | (17%) 90.39K to 74.6K | |
| 28-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 12,141 | $227.86 | $2,766,450.00 | (12%) 102.53K to 90.39K | |
| 22-Feb-22 4:57 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 8,236 | $232.51 | $1,914,950.00 | (7%) 110.77K to 102.53K | |
| 03-Feb-22 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-22 | Payment of Exercise | 6,279 | $243.63 | $1,529,750.00 | (5%) 117.05K to 110.77K | |
| 03-Feb-22 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 66,817 | -- | -- | 133% 50.23K to 117.05K | |
| 19-Feb-21 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 13,970 | $211.75 | $2,958,150.00 | (22%) 64.09K to 50.12K | |
| 12-Feb-21 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 13,954 | $214.16 | $2,988,390.00 | (18%) 78.04K to 64.09K | |
| 05-Feb-21 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 83,888 | -- | -- | 3049% 2.75K to 86.64K | |
| 05-Feb-21 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Payment of Exercise | 8,599 | $215.03 | $1,849,040.00 | (10%) 86.64K to 78.04K | |
| 02-Jul-20 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Jun-20 | Private Sale (Planned) | 32,792 | $286.15 | $9,383,300.00 | (92%) 35.49K to 2.7K | |
| 14-May-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-May-20 | Option Exercise | 88,532 | $137.52 | $12,174,600.00 | 215% 41.26K to 129.79K | |
| 14-May-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-May-20 | Planned Option Sale | 88,532 | $283.47 | $25,096,500.00 | (68%) 129.79K to 41.26K | |
| 14-May-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-May-20 | Sale (Planned) | 5,838 | $283.47 | $1,654,920.00 | (14%) 41.26K to 35.42K | |
| 08-May-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-20 | Option Exercise | 88,534 | $137.52 | $12,175,000.00 | 188% 47.1K to 135.63K | |
| 08-May-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-20 | Planned Option Sale | 88,534 | $269.78 | $23,884,800.00 | (65%) 135.63K to 47.1K | |
| 08-May-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-20 | Sale (Planned) | 5,835 | $269.78 | $1,574,180.00 | (12%) 47.1K to 41.26K | |
| 07-May-20 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-20 | Option Exercise | 88,537 | $137.52 | $12,175,300.00 | 167% 52.93K to 141.47K | |
| 07-May-20 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-20 | Planned Option Sale | 88,537 | $269.94 | $23,899,900.00 | (63%) 141.47K to 52.93K | |
| 07-May-20 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-20 | Sale (Planned) | 5,835 | $269.94 | $1,575,120.00 | (11%) 52.93K to 47.1K | |
| 02-Apr-20 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Mar-20 | Payment of Exercise | 40,090 | $234.01 | $9,381,460.00 | (43%) 93.02K to 52.93K | |
| 26-Feb-20 4:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-20 | Sale (Planned) | 10,550 | $233.46 | $2,463,050.00 | (10%) 103.57K to 93.02K | |
| 26-Feb-20 4:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 8,410 | $239.23 | $2,011,920.00 | (8%) 111.98K to 103.57K | |
| 19-Feb-20 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-20 | Sale (Planned) | 11,685 | $243.52 | $2,845,520.00 | (9%) 123.67K to 111.98K | |
| 19-Feb-20 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-20 | Payment of Exercise | 9,314 | $241.50 | $2,249,330.00 | (7%) 132.98K to 123.67K | |
| 12-Feb-20 5:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-20 | Sale (Planned) | 47,523 | $246.09 | $11,694,900.00 | (26%) 180.5K to 132.98K | |
| 12-Feb-20 5:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-20 | Payment of Exercise | 36,755 | $240.95 | $8,856,120.00 | (17%) 217.26K to 180.5K |